Your session is about to expire
← Back to Search
Testosterone Treatment for Chronic Kidney Disease
Study Summary
This trial is testing the effectiveness of a testosterone supplement in men with low testosterone and kidney disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 4 trial • 22 Patients • NCT01208038Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not had a blood clot in my veins or lungs in the last 3 months.My kidney function is moderately to severely reduced.I have used testosterone replacement therapy or androgen supplements in the last 6 months.I started iron replacement therapy within the last 3 months.Your hematocrit level is higher than 48%.Your blood pressure is not well controlled and is very high.I have breast cancer.I have not had a heart attack, stroke, or heart surgery in the last 3 months.I am a man aged between 18 and 85.I have severe sleep apnea that hasn't been treated.You plan to have a baby in the next year.My heart condition severely limits my daily activities.I have had deep vein clots or lung clots more than once.I have a history of prostate cancer.I am being treated with drugs to help increase my red blood cells.My morning testosterone levels were below 300 ng/dl twice.Your blood test shows that you have enough iron in your body.I experience symptoms like low sex drive, mood changes, and changes in my body composition.Your PSA level is higher than 4 ng/ml, unless a urologist has confirmed that you don't have prostate cancer (and this is written in your medical notes).I experience symptoms like low sex drive, mood changes, and changes in my body composition.I am taking warfarin.I have HIV or untreated hepatitis C.Your blood iron levels are within a certain range: ferritin is at least 100 ng/mL and transferrin saturation is at least 20%.
- Group 1: treatment
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any unfilled appointments in this research project?
"The trial, which is currently ongoing, was first posted on March 15th, 2022 and has since been updated."
If I enroll, am I allowed to finish the whole program?
"This study, which is looking for 20 participants, requires that patients have hypogonadism and be between 18-85 years old."
Will this experiment be testing seniors over the age of 70?
"Eligibility for this particular clinical trial is restricted to patients aged between 18 and 85. In contrast, there are 46 other trials available for minors and 495 targeting a senior demographic."
Did the FDA sign off on Jatenzo Pill?
"Jatenzo Pill's safety is estimated to be a 2. Although there is no data currently supporting efficacy, there are Phase 2 trial results indicating that Jatenzo is safe for human use."
How many people are recruited for this clinical trial at most?
"That is correct, the online clinicaltrials.gov registry currently lists this trial as open and recruiting patients. This particular study was posted on March 15th, 2022 and edited on the same day. There is a total of 20 spots available for participants at a single location."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger